Clinical Trials Browser

Phase 3 × Doxorubicin × Genitourinary × Clear all

NCT06401330 2026-03-05

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

Phase 3 Recruiting

Stage I Mixed Cell Type Kidney Wilms Tumor

NCT06960577 2026-02-23

Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)

Phase 3 Recruiting

Urinary Bladder Neoplasms

NCT00945009 2025-05-31

Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor

Phase 3 Active not recruiting

249 enrolled 14 charts

Beckwith-Wiedemann Syndrome, Wilms Tumor

NCT00003376 2023-06-22

Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium

Phase 3 Completed

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00003701 2023-06-15

Combination Chemotherapy in Treating Patients With Bladder Cancer

Phase 3 Completed

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00030654 2020-10-22

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00002855 2018-10-31

Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00005047 2017-06-08

4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer

Phase 3 Terminated

521 enrolled 18 charts

Urinary Bladder Neoplasms

NCT00028756 2016-08-02

Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium

Phase 3 Completed

Urinary Bladder Neoplasms

NCT00014534 2016-07-14

Combination Chemotherapy in Treating Patients With Bladder Cancer

Phase 3 Completed

Urinary Bladder Neoplasms

NCT00003682 2016-06-23

Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer

Phase 3 Terminated

Prostatic Neoplasms

NCT00024167 2016-03-22

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

Phase 3 Terminated

265 enrolled 9 charts

Prostatic Neoplasms

NCT00002641 2014-08-08

Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma

Phase 3 Completed

EndocrineGenitourinaryGynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Fibrosarcoma, Hemangiosarcoma, Kidney Neoplasms, Leiomyosarcoma, Liposarcoma, Ovarian Neoplasms, Pheochromocytoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Endometrial Neoplasms, Sarcoma, Endometrial Stromal, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT00002610 2014-07-25

Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors

Phase 3 Completed

Kidney Neoplasms, Wilms Tumor

NCT00047138 2014-06-24

Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor

Phase 3 Unknown

Kidney Neoplasms, Wilms Tumor

NCT00006034 2013-05-15

Keyhole Limpet Hemocyanin Compared With Doxorubicin in Treating Patients With Bladder Cancer

Phase 3 Completed

Urinary Bladder Neoplasms

NCT00002764 2012-07-11

Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma

Phase 3 Completed

EndocrineGenitourinaryGynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Fibrosarcoma, Hemangiosarcoma, Kidney Neoplasms, Leiomyosarcoma, Liposarcoma, Neoplasm Metastasis, Ovarian Neoplasms, Pheochromocytoma, Sarcoma, Sarcoma, Synovial, Endometrial Neoplasms, Sarcoma, Endometrial Stromal, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous